Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
TWST - Twist Bioscience Corporation
Market Cap 1.22B P/E - EPS this Y 16.10% Ern Qtrly Grth -
Income -192.14M Forward P/E -6.79 EPS next Y 17.20% 50D Avg Chg 8.00%
Sales 277.49M PEG -0.10 EPS past 5Y - 200D Avg Chg -1.00%
Dividend N/A Price/Book 1.74 EPS next 5Y 150.00% 52W High Chg -64.00%
Recommedations 2.10 Quick Ratio 4.90 Shares Outstanding 58.23M 52W Low Chg 87.00%
Insider Own 1.75% ROA -15.63% Shares Float 57.34M Beta 1.63
Inst Own 112.86% ROE -30.40% Shares Shorted/Prior 11.93M/12.26M Price 21.39
Gross Margin 38.30% Profit Margin -69.24% Avg. Volume 1,268,609 Target Price 43.76
Oper. Margin -64.92% Earnings Date Aug 2 Volume 1,361,700 Change -6.55%
Healthcare | Diagnostics & Research | United States
About Twist Bioscience Corporation

Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Twist Bioscience Corporation News
05/13/24 Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
05/10/24 Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
05/08/24 Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/04/24 Earnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
05/03/24 Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised
05/03/24 Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript
05/03/24 Q2 2024 Twist Bioscience Corp Earnings Call
05/03/24 Twist Bioscience Corp (TWST) Q2 2024 Earnings Call Transcript Highlights: Key Financial ...
05/02/24 Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
05/02/24 Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
04/30/24 3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
04/18/24 Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
04/05/24 Despite shrinking by US$135m in the past week, Twist Bioscience (NASDAQ:TWST) shareholders are still up 132% over 1 year
03/28/24 Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
03/05/24 Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
02/22/24 Twist Bioscience to Present at Upcoming Investor Conferences
02/13/24 7 Stocks Cathie Wood Is Still Loading Up On in Q1
02/10/24 Twist Bioscience Corp Director Robert Chess Sells 4,110 Shares
02/06/24 Twist Bioscience Corporation (NASDAQ:TWST) Analysts Are Pretty Bullish On The Stock After Recent Results
02/06/24 Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
TWST Chatroom

User Image FlynancialAnalyst Posted - 22 hours ago

$TWST $2.71B mc $XLV / $ARKG name with a spectacular move above now-rising 10/40/80 wk SMAs over the past 4 weeks #ShortSqueeze candidate as short float % is declining from 27.31% to 20.81% YTD FOUNDER LED, fully institutionally owned... dips into $40 are 🎁s... if only am so lucky to get them TrendEdge.app/asset/TWST

User Image Santanatrading Posted - 2 days ago

$TWST TALKING TO MYSELF HERE, BUT I JUST KNOW THIS STOCK TOO WELL 🫢🩸

User Image Santanatrading Posted - 2 days ago

$TWST 🩸🩸🩸🩸🩸🩸🩸🩸🩸

User Image StockInvest_us Posted - 2 days ago

Signal alert: $TWST - Overbought Trend Short (Overvalued) https://stockinvest.us/l/a3sEd7IsyL

User Image Plan2TradeTrade2Plan Posted - 2 days ago

$TWST calling for a high of around $52 tomorrow. GLA

User Image Santanatrading Posted - 2 days ago

$TWST VERY EASY SHORT UNTIL $42 🔴🔴🔴🔴🔴

User Image Madmanxx Posted - 2 days ago

$TWST crkn

User Image Santanatrading Posted - 3 days ago

$TWST MASSIVE BLEEDING INCOMING 🩸🩸🩸🩸🩸🩸

User Image AdrianRoth Posted - 3 days ago

$TWST more spread on this than my ex. 🤷🏻‍♂️

User Image TheMercantilist Posted - 3 days ago

$TWST retard that was eons ago I sold at 13 that year

User Image RemitTekram Posted - 3 days ago

$TWST My $15.89 cost basis is doing so F'ing well !!! Go TWIST Go.

User Image Tech2020 Posted - 3 days ago

$TWST Still has more legs, as the market continues to rally to new 52 week highs.....$$$$ Shorts are in trouble here !!!!

User Image sohoonak Posted - 4 days ago

$TWST I wanna see how it will nose down.......when pumpers like Woods will leave the scene with money bags......

User Image BlazingStocks Posted - 4 days ago

$RENB - States Daan Vessies, senior scientist at RenovaroCube: "Flamingo undescores our commitment to change cancer diagnostics in a transformative way, ultimately offering clinicians a powerful tool to detect cancer across diverse omic layers." https://finance.yahoo.com/news/transforming-cancer-detection-renovarocube-introduces-150000564.html $TWST

User Image BlazingStocks Posted - 4 days ago

$RENB - Flamingo has the potential to overcome these traditional limitations by harnessing the power of AI to analyze minute amounts of cfDNA data that is highly accurate. https://finance.yahoo.com/news/transforming-cancer-detection-renovarocube-introduces-150000564.html $TWST

User Image BlazingStocks Posted - 5 days ago

$RENB - unveils Flamingo, a potentially groundbreaking multi-cancer detection model contributing to its mission to transform early cancer diagnostics. Leveraging ultra-low pass whole genome sequencing (ULP-WGS) of cell-free DNA (cfDNA), Flamingo represents a promising leap forward in the fight against cancer. https://finance.yahoo.com/news/transforming-cancer-detection-renovarocube-introduces-150000564.html $TWST

User Image AdrianRoth Posted - 5 days ago

$TWST feeling comfortable all the way to 58$ - should be a short sprint from here.

User Image WantedToRetireEarly Posted - 5 days ago

$RXRX $DNA $TWST fascinating stuff. One of these years this stuff I’m convinced will lead to major breakthroughs in the speed of drug discovery. Still too early to bet on at scale. Who knows when these companies will make money. But it’s coming. 2028? 2030? https://finance.yahoo.com/news/recursion-announces-completion-nvidia-powered-090000317.html

User Image WOLFSTREET Posted - 5 days ago

$TWST What an ignoramous, telling me $19 inbound when $30, instead runs 90% north for cool smooth profits. You cannot make this up, compliments of the COMPASS. It is not you against me, it is you against my COMPASS, unfortunately a totally unfair contest.

User Image WOLFSTREET Posted - 5 days ago

$TWST Up almost 90% in 14-15 months! WOW Just getting started too, says the COMPASS...

User Image PulsarTrades Posted - 5 days ago

Space to $60 opening up $TWST

User Image Doozio Posted - 5 days ago

Don’t get it $twst ed. Coming out of bahhh first 🐑 correction from the initial DASH of 🧠⏰.

User Image AnchorsAweigh Posted - 5 days ago

@Doozio check out $TWST

User Image AnchorsAweigh Posted - 5 days ago

$TWST

User Image Yassine727 Posted - 5 days ago

$TWST

User Image AdrianRoth Posted - 5 days ago

$TWST ok ladies and gents… this will be an interesting week. Let’s all hit this with a couple of repetitive 100 share buys at open to give it to the shorts without vaseline.

User Image WantedToRetireEarly Posted - 5 days ago

$DNA As I've said over and over again here, $TWST is the only valid synth bio investment out there currently. Up 10% today on this news: https://finance.yahoo.com/news/twist-bioscience-launches-multiplexed-gene-120000078.html

User Image ezcmezwent Posted - 6 days ago

@Stocktwits It’s time to $TWST and shout

User Image Plan2TradeTrade2Plan Posted - 6 days ago

$TWST could see $200 again soon

User Image RemitTekram Posted - 6 days ago

$TWST CHEERS TO THE BULLS! My 3rd 10% today.

Analyst Ratings
Scotiabank Sector Outperform May 6, 24
Evercore ISI Group Outperform May 3, 24
Barclays Overweight May 3, 24
Baird Outperform May 3, 24
Barclays Overweight Apr 10, 24
Scotiabank Sector Outperform Feb 5, 24
Barclays Overweight Jan 25, 24
Goldman Sachs Buy Jan 18, 24
Goldman Sachs Buy Jan 17, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Green Paula SVP of Human Resourc.. SVP of Human Resources Sep 16 Option 5.95 8,514 50,658 22,610 09/20/22
Green Paula SVP of Human Resourc.. SVP of Human Resources Sep 16 Sell 37.43 8,514 318,679 14,199 09/20/22
THORBURN JAMES M Chief Financial Offi.. Chief Financial Officer Aug 16 Option 11.59 9,000 104,310 47,831 08/18/22
THORBURN JAMES M Chief Financial Offi.. Chief Financial Officer Aug 16 Sell 50.06 13,900 695,834 38,831 08/18/22
Banyai William See Remarks See Remarks Jul 22 Sell 43.19 378 16,326 258,729 07/26/22
THORBURN JAMES M Chief Financial Offi.. Chief Financial Officer Apr 14 Option 20.53 6,620 135,909 53,308 04/18/22
THORBURN JAMES M Chief Financial Offi.. Chief Financial Officer Apr 14 Sell 43.12 6,620 285,454 46,688 04/18/22
Banyai William See Remarks See Remarks Apr 01 Sell 53.61 318 17,048 262,455 04/05/22
Banyai William See Remarks See Remarks Feb 18 Sell 52.66 1,280 67,405 263,073 02/23/22
THORBURN JAMES M Chief Financial Offi.. Chief Financial Officer Feb 18 Option 25 3,517 87,925 51,442 02/23/22
THORBURN JAMES M Chief Financial Offi.. Chief Financial Officer Feb 18 Sell 52.86 4,442 234,804 47,000 02/23/22
Banyai William See Remarks See Remarks Jan 24 Sell 54.73 348 19,046 265,174 01/26/22
Banyai William See Remarks See Remarks Oct 22 Sell 117.39 19,791 2,323,265 306,378 10/26/21
Leproust Emily M. President & CEO President & CEO Oct 21 Option 5.95 1,740 10,353 174,222 10/25/21
Leproust Emily M. President & CEO President & CEO Oct 21 Sell 120.99 1,740 210,523 172,482 10/25/21
Weiss Patrick Chief Operating Offi.. Chief Operating Officer Oct 13 Option 20.17 4,906 98,954 53,902 10/15/21
Weiss Patrick Chief Operating Offi.. Chief Operating Officer Oct 13 Sell 104 4,906 510,224 48,996 10/15/21
Banyai William See Remarks See Remarks Oct 13 Option 7.39 28,181 208,258 326,457 10/15/21
Leproust Emily M. President & CEO President & CEO Oct 13 Option 5.95 1,740 10,353 174,222 10/15/21
Leproust Emily M. President & CEO President & CEO Oct 13 Sell 110.16 1,740 191,678 172,482 10/15/21
Leproust Emily M. President & CEO President & CEO Oct 06 Option 5.95 8,700 51,765 174,222 10/08/21
Leproust Emily M. President & CEO President & CEO Oct 06 Sell 99.05 8,700 861,735 172,482 10/08/21
Leproust Emily M. President & CEO President & CEO Sep 13 Sell 118.46 29,587 3,504,876 219,143 09/13/21
Leproust Emily M. President & CEO President & CEO Sep 13 Option 7.39 29,587 218,648 233,063 09/13/21
JOHANNESSEN JAN Director Director Aug 20 Option 14 5,000 70,000 6,898 08/20/21
JOHANNESSEN JAN Director Director Aug 20 Sell 97.11 5,000 485,550 1,898 08/20/21
Weiss Patrick Chief Operating Offi.. Chief Operating Officer May 21 Option 20.17 4,905 98,934 57,109 05/21/21
JOHANNESSEN JAN Director Director May 21 Option 14 5,000 70,000 6,898 05/21/21
THORBURN JAMES M Chief Financial Offi.. Chief Financial Officer Apr 26 Option 11.59 5,000 57,950 53,034 04/26/21
THORBURN JAMES M Chief Financial Offi.. Chief Financial Officer Apr 26 Sell 133.47 5,000 667,350 48,034 04/26/21
Leproust Emily M. President & CEO President & CEO Apr 15 Sell 128.84 2,000 257,680 265,843 04/15/21
Finn Patrick John Chief Commercial Off.. Chief Commercial Officer Apr 07 Option 19.6 2,702 52,959 45,446 04/07/21
Finn Patrick John Chief Commercial Off.. Chief Commercial Officer Apr 07 Sell 126.72 2,702 342,397 42,744 04/07/21
Daniels Mark See Remarks See Remarks Feb 26 Option 23.33 620 14,465 67,546 02/26/21
Daniels Mark See Remarks See Remarks Feb 26 Sell 134.31 620 83,272 66,926 02/26/21
Banyai William See Remarks See Remarks Feb 24 Sell 144.18 20,275 2,923,250 440,987 02/24/21
Leproust Emily M. President & CEO President & CEO Feb 11 Sell 178.43 75,000 13,382,250 02/11/21
Finn Patrick John Chief Commercial Off.. Chief Commercial Officer Feb 04 Option 19.6 2,702 52,959 46,729 02/04/21
Finn Patrick John Chief Commercial Off.. Chief Commercial Officer Feb 04 Sell 183.59 2,702 496,060 44,027 02/04/21
Daniels Mark See Remarks See Remarks Feb 01 Option 8.82 377 3,325 68,577 02/01/21
Daniels Mark See Remarks See Remarks Feb 01 Sell 161.02 377 60,705 68,200 02/01/21
Green Paula SVP of Human Resourc.. SVP of Human Resources Jan 26 Sell 193 246 47,478 22,250 01/26/21
Daniels Mark See Remarks See Remarks Jan 26 Option 23.33 620 14,465 68,820 01/26/21
Daniels Mark See Remarks See Remarks Jan 26 Sell 193 905 174,665 68,200 01/26/21
Banyai William See Remarks See Remarks Jan 26 Sell 192.95 14,099 2,720,402 461,937 01/26/21
Leproust Emily M. President & CEO President & CEO Jan 19 Sell 182.92 10,000 1,829,200 421,196 01/19/21
Finn Patrick John Chief Commercial Off.. Chief Commercial Officer Jan 07 Option 19.6 2,702 52,959 46,930 01/07/21
Finn Patrick John Chief Commercial Off.. Chief Commercial Officer Jan 07 Sell 132.93 2,702 359,177 44,228 01/07/21
Daniels Mark See Remarks See Remarks Dec 29 Option 16.08 997 16,032 69,164 12/29/20
Daniels Mark See Remarks See Remarks Dec 29 Sell 167.45 997 166,948 68,787 12/29/20